FIELD: biotechnology.
SUBSTANCE: described is a group of inventions comprising a dry composition for vaccination of an animal against a viral infection, a composition for vaccination against canine parainfluenza virus, as well as a method for vaccination of a dog against canine parainfluenza virus. In one embodiment, the composition contains a live attenuated parvovirus, sugar alcohol in amount of 10% to 80 (w/w)%, a stabilizing filler from 10% to 70 (w/w)%, a protein stabilizer from 4% to 50 (w/w)% and a buffer having pH of 6.8 to 8.0.
EFFECT: invention extends the range of products for animal vaccination against viral infection.
9 cl, 20 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINES, STABLE AT ROOM TEMPERATURE | 2014 |
|
RU2740920C2 |
| LIQUID STABLE VIRAL VACCINES | 2013 |
|
RU2641970C2 |
| RECOVERING VIRUS RELATED TO CANINE PARVOVIRUS-2 FROM RACOON | 2010 |
|
RU2565538C2 |
| VACCINES WITH REDUCED FOAM FORMATION | 2015 |
|
RU2731534C2 |
| METHOD FOR PRODUCING MEDICAMENT INCLUDING BIOLOGICALLY ACTIVE PROTEIN, AND FINAL PRODUCT | 2013 |
|
RU2663581C2 |
| ASSOCIATED VACCINE AGAINST CANINE DISTEMPER, PARVOVIRUS AND CORONAVIRUS ENTERITIS, ADENOVIRUS INFECTION OF DOGS | 2022 |
|
RU2806164C1 |
| VACCINES BASED ON VIRUS-LIKE PARTICLES (VLP) OF CANINE PARVOVIRUS (CPV) AND APPLICATION THEREOF | 2016 |
|
RU2710854C1 |
| ASSOCIATED VACCINE AGAINST DISTEMPER, PARVOVIRUS AND CORONAVIRUS ENTERITIS, ADENOVIRUS INFECTION AND CANINE RABIES | 2023 |
|
RU2817255C1 |
| VACCINE AGAINST PLAGUE, ADENOVIRUS INFECTIONS, PARVOVIRUS AND CORONAVIRUS ENTERITIS, LEPTOSPIROSIS AND RABIES OF DOGS | 2013 |
|
RU2546247C2 |
| ATTENUATED RECOMBINANT PARVOVIRUS APPLICABLE FOR DOG PROTECTION AGAINST PARVOVIRUS INFECTION | 2011 |
|
RU2527157C2 |
